𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety, immunogenicity, and kinetics of the immune response to a single dose of virosome-formulated hepatitis A vaccine in Thais

✍ Scribed by Yong Poovorawan; Apiradee Theamboonlers; Saowani Chumdermpadetsuk; Reinhard Glück; Stanley J. Cryz Jr

Book ID
116116742
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
345 KB
Volume
13
Category
Article
ISSN
0264-410X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Single dose inactivated hepatitis A vacc
Single dose inactivated hepatitis A vaccine: Rationale and clinical assessment of the safety and immunogenicity
✍ Dr. P. van Damme; C. Matheï; S. Thoelen; A. Meheus; A. Safary; F. E. André 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 537 KB

## Abstract In comparison with the classical immunisation schedules (0‐1‐6 or 0‐1‐12 months) for hepatitis A, a 0‐ and 12‐ or a 0‐ and 6‐month schedule would have important advantages by reducing the number of injections and discomfort and increasing scheduling convenience and patient compliance. I

Immunogenicity and safety in adults of h
Immunogenicity and safety in adults of hepatitis A virus vaccine administered as a single dose with a booster 6 months later
✍ H. Briem; A. Safary 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB

## Abstract An inactivated vaccine against hepatitis A was administered as a single 1,440 enzyme‐linked immunosorbent assay (ELISA) units dose at month 0 with a booster at month 6 to 200 subjects divided into two age groups: group 1, 20–39 years (n = 134) and group II, 40–62 years (n = 66). At day